Onyx Pharmaceuticals Number of Employees

  

Number of Employees Analysis

Number of Employees shows total number of permanent full time and part time employees working for a given company and processed through its payroll.
Onyx Pharmaceuticals 
Number of Employees 
 = 
Full Time 
+  
Part Time 
 = 
741

Distress Driver Correlations

About Number of Employees

Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.Compare Onyx Pharmaceuticals to competition
Based on recorded statements Onyx Pharmaceuticals Inc is currently employing 741 people. This is much higher than that of the sector, and significantly higher than that of Number of Employees industry, The Number of Employees for all stocks is over 1000% lower than the firm.
ETFsFundsStocks

Filter other Stocks by Number of Employees

Number of Employees Input Range 
Industry  
Click to run this filter
Filter Other Equities
  
Found 10 equities by Number of Employees
CGUIY PNKCASINO GUICHARD PERR
0
FNMFO PNKFederal National Mortgage Association
7 K
TEVA TLVTeva Pharmaceutical Industries Limited
42.89 K
FNMFO PNKFED NATL MTG PFD I
7 K
096770 KRXSK Innovation
1.81 K
KDDIF PNKKDDI Corp
18.42 K
JAPAF PNKJapan Tobacco Inc
48.47 K
AMKBF PNKAP M
117 K
POLI TLVBank Hapoalim BM
11.93 K
CTGBZ PNKCitigroup Inc
30
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  
Did you try this?
Run Money Flow Index Now
   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
Hide  View All  NextLaunch Money Flow Index
Return On Equity(12.15) %
Return On Asset(6.89) %
Profit Margin(21.78) %
Operating Margin(32.53) %
Current Valuation8.01 B
Shares Outstanding73.34 M
Shares Owned by Insiders1.31 %
Shares Owned by Institutions103.70 %
Number of Shares Shorted5.49 M
Price to Earning439.11 times
Price to Book7.97 times
Price to Sales17.73 times
Revenue515.95 M
Gross Profit360.84 M
EBITDA(151.48 M)
Net Income(112.36 M)
Cash and Equivalents750.46 M
Cash per Share10.23 times
Total Debt180.7 M
Debt to Equity0.16 times
Current Ratio8.35 times
Book Value Per Share15.65 times
Cash Flow from Operations(258.03 M)
Short Ratio1.70 times
One Year High136.87
One Year Low68.12
Earnings Per Share(1.62) times
Price to Earnings To Growth(1.79) times
Number of Employees741
Beta2.0
Market Capitalization9.15 B
Total Asset1.68 B
Retained Earnings(737.91 M)
Working Capital899.37 M
Current Asset1.02 B
Current Liabilities122.35 M
Z Score30.0